Concentrix Co. (NASDAQ:CNXC) Director Buys $25,110.00 in Stock

Concentrix Co. (NASDAQ:CNXC - Get Free Report) Director Kathryn Hayley purchased 500 shares of the company's stock in a transaction dated Wednesday, January 22nd. The shares were purchased at an average cost of $50.22 per share, for a total transaction of $25,110.00. Following the transaction, the director now directly owns 3,034 shares in the company, valued at approximately $152,367.48. The trade was a 19.73 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.

Concentrix Price Performance

NASDAQ CNXC traded up $2.12 during trading on Thursday, reaching $52.44. The company's stock had a trading volume of 899,047 shares, compared to its average volume of 858,421. The stock has a market capitalization of $3.40 billion, a PE ratio of 14.13, a P/E/G ratio of 0.70 and a beta of 0.63. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.42 and a quick ratio of 1.57. The firm has a fifty day moving average of $44.12 and a 200 day moving average of $54.44. Concentrix Co. has a one year low of $36.28 and a one year high of $106.10.

Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings data on Wednesday, January 15th. The company reported $3.26 EPS for the quarter, beating the consensus estimate of $3.01 by $0.25. The firm had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.44 billion. Concentrix had a return on equity of 16.67% and a net margin of 2.61%. The company's revenue was up 9.7% on a year-over-year basis. During the same period in the prior year, the company earned $3.36 EPS. Analysts expect that Concentrix Co. will post 10.11 EPS for the current fiscal year.

Concentrix Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 11th. Stockholders of record on Friday, January 31st will be given a dividend of $0.3328 per share. The ex-dividend date is Friday, January 31st. This represents a $1.33 annualized dividend and a dividend yield of 2.54%. Concentrix's dividend payout ratio (DPR) is presently 35.85%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CNXC. Bank of America dropped their price target on Concentrix from $85.00 to $70.00 and set a "neutral" rating on the stock in a research report on Thursday, September 26th. Canaccord Genuity Group decreased their price objective on Concentrix from $100.00 to $80.00 and set a "buy" rating on the stock in a research note on Thursday, January 16th. Robert W. Baird assumed coverage on Concentrix in a research note on Thursday, October 3rd. They set an "outperform" rating and a $70.00 price objective on the stock. Baird R W upgraded Concentrix to a "strong-buy" rating in a research note on Thursday, October 3rd. Finally, Barrington Research decreased their price objective on Concentrix from $84.00 to $70.00 and set an "outperform" rating on the stock in a research note on Thursday, September 26th. One analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $75.00.

Hedge Funds Weigh In On Concentrix

Several institutional investors have recently modified their holdings of CNXC. State Street Corp boosted its holdings in Concentrix by 1.3% during the 3rd quarter. State Street Corp now owns 1,401,953 shares of the company's stock valued at $71,850,000 after acquiring an additional 18,304 shares during the period. Copeland Capital Management LLC boosted its holdings in Concentrix by 1.8% during the 3rd quarter. Copeland Capital Management LLC now owns 1,003,375 shares of the company's stock valued at $51,423,000 after acquiring an additional 17,653 shares during the period. Geode Capital Management LLC boosted its holdings in Concentrix by 5.2% during the 3rd quarter. Geode Capital Management LLC now owns 878,092 shares of the company's stock valued at $45,013,000 after acquiring an additional 43,295 shares during the period. AQR Capital Management LLC boosted its holdings in Concentrix by 74.4% during the 2nd quarter. AQR Capital Management LLC now owns 813,864 shares of the company's stock valued at $51,160,000 after acquiring an additional 347,230 shares during the period. Finally, Invenomic Capital Management LP boosted its holdings in Concentrix by 354.3% during the 3rd quarter. Invenomic Capital Management LP now owns 472,243 shares of the company's stock valued at $24,202,000 after acquiring an additional 368,295 shares during the period. 90.34% of the stock is currently owned by institutional investors.

About Concentrix

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.